RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock
$2.88
가격 · 5월 20, 2026
기준 재무 정보 5월 6, 2026
52주 범위
$3–$7
2% of range
애널리스트 평점
BUY
14 analysts
목표 주가
$7
+131% upside
P/E (TTM)
-2.8
ROE
-62.9%
순이익률
-863.4%
RXRX 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$2.88
시가총액
$2.16B
P/E (TTM)
-2.8
EPS (TTM)
$-1.44
매출 (TTM)
$75M
배당 수익률
—
ROE
-62.9%
부채/자본
—
52주 범위
$3 – $7
RXRX 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$75M
2019-12-31
→
2025-12-31
EPS
$-1.44
2019-12-31
→
2025-12-31
잉여현금흐름
$-378M
2021-12-31
→
2025-12-31
마진
-863.4%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
RXRX
동종업계 중앙값
P/E (TTM)
-2.8
—
P/S (TTM)
28.9
45.5
P/B
1.9
4.8
Price / FCF (주가 / FCF)
-5.7
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
RXRX
동종업계 중앙값
Operating Margin (영업이익률)
-867.9%
—
Net Profit Margin (순이익률)
-863.4%
-237.1%
ROA
-44.1%
-41.6%
ROE
-62.9%
-55.3%
ROIC
-57.3%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
RXRX
동종업계 중앙값
Current Ratio (유동비율)
5.5
5.7
Quick Ratio (당좌 비율)
5.0
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
RXRX
동종업계 중앙값
Revenue YoY (매출 YoY)
26.9%
—
Revenue CAGR 3Y (매출 CAGR 3년)
23.3%
—
Revenue CAGR 5Y (매출 CAGR 5년)
79.9%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
RXRX
동종업계 중앙값
RXRX 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
14 명의 애널리스트
- 적극 매수 2 14.3%
- 매수 6 42.9%
- 보유 6 42.9%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
7 명의 애널리스트 · 2026-05-16
중앙값
$6.00
평균
$6.64
← 모든 목표가 하회
$2.88
저가
$3.00
고가
$10.00
중앙값 목표
$6.00
+108.5%
평균 목표
$6.64
+130.8%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.03%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.22 | $-0.28 | 0.06% |
| 2025년 12월 31일 | $-0.21 | $-0.32 | 0.11% |
| 2025년 9월 30일 | $-0.36 | $-0.38 | 0.02% |
| 2025년 6월 30일 | $-0.41 | $-0.36 | -0.05% |
| 2025년 3월 31일 | $-0.50 | $-0.54 | 0.04% |
동료 비교 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| KALV | $685M | -3.7 | — | — | -172.9% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $75M | $59M | $45M | $40M | $10M | $4M | $2M | |
| Cost of Revenue | $71M | $45M | $43M | $48M | $0 | $0 | · | |
| R&D Expense | $475M | $314M | $241M | $156M | $135M | $63M | $46M | |
| SG&A Expense | $177M | $178M | $111M | $82M | $58M | $25M | $19M | |
| Operating Expenses | $723M | $538M | $395M | $286M | $193M | $89M | $65M | |
| Operating Income | $-648M | $-479M | $-350M | $-246M | $-183M | $-85M | $-62M | |
| Interest Expense | · | · | $97.0K | $55.0K | $3M | $1M | $635.0K | |
| Other Non-op | $3M | $14M | $18M | $6M | $-4M | $-2M | $562.0K | |
| Pretax Income | $-645M | $-465M | $-332M | $-239M | $-186M | · | · | |
| Income Tax | $-136.0K | $-1M | $-4M | $0 | $0 | $0 | $0 | |
| Net Income | $-645M | $-464M | $-328M | $-239M | $-186M | $-87M | $-62M | |
| EPS (Basic) | $-1.44 | $-1.69 | $-1.58 | $-1.36 | $-1.49 | $-3.99 | $-2.87 | |
| EPS (Diluted) | $-1.44 | $-1.69 | $-1.58 | $-1.36 | $-1.49 | $-3.99 | $-2.87 | |
| Shares (Basic) | 447,446,109 | 274,207,146 | 207,853,702 | 175,537,487 | 125,348,110 | 21,781,386 | 21,570,265 | |
| Shares (Diluted) | 447,446,109 | 274,207,146 | 207,853,702 | 175,537,487 | 125,348,110 | 21,781,386 | 21,570,265 | |
| EBITDA | $-564M | $-443M | $-326M | $-234M | $-174M | · | · |
대차대조표 30
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $743M | $594M | $392M | $550M | $285M | $262M | · | |
| Short-term Investments | · | · | · | $0 | $231M | $0 | · | |
| Receivables | · | · | · | $0 | $34.0K | $156.0K | · | |
| Prepaid Expense | $12M | $30M | · | · | · | · | · | |
| Other Current Assets | $29M | $38M | $40M | $16M | $8M | $2M | · | |
| Current Assets | $813M | $714M | $438M | $570M | $535M | $266M | · | |
| PP&E (Net) | $104M | $141M | $87M | $88M | $65M | $26M | · | |
| PP&E (Gross) | $193M | $204M | $131M | $118M | $83M | $36M | · | |
| Accum. Depreciation | $89M | $63M | $45M | $30M | $19M | $10M | · | |
| Goodwill | $162M | $149M | $52M | $801.0K | $801.0K | $801.0K | · | |
| Intangibles | $310M | $336M | $36M | $1M | $1M | $2M | · | |
| Other Non-current Assets | $13M | $9M | $261.0K | $0 | $35.0K | $650.0K | · | |
| Total Assets | $1.47B | $1.45B | $654M | $701M | $610M | $299M | · | |
| Accounts Payable | $18M | $22M | $4M | $5M | $3M | $1M | · | |
| Accrued Liabilities | $70M | $82M | $47M | $33M | $32M | $10M | · | |
| Short-term Debt | · | · | $41.0K | $97.0K | $90.0K | $1M | · | |
| Current Liabilities | $148M | $187M | $93M | $100M | $47M | $23M | · | |
| Capital Leases | $47M | $67M | $43M | $44M | $0 | · | · | |
| Deferred Tax | $23M | $17M | $1M | $0 | · | · | · | |
| Other Non-current Liabilities | $2M | $5M | $0 | · | · | · | · | |
| Total Liabilities | $343M | $414M | $190M | $215M | $67M | $57M | · | |
| Long-term Debt | · | · | · | · | $723.0K | · | · | |
| Total Debt | · | · | $41.0K | $97.0K | $90.0K | · | · | |
| Common Stock | $5.0K | $4.0K | $2.0K | $2.0K | $2.0K | $0 | · | |
| Paid-in Capital | $3.17B | $2.47B | $1.43B | $1.13B | $943M | $7M | · | |
| Retained Earnings | $-2.08B | $-1.43B | $-968M | $-640M | $-400M | $-214M | · | |
| AOCI | $37M | $-8M | $0 | $0 | $-126.0K | $0 | · | |
| Stockholders' Equity | $1.13B | $1.03B | $463M | $486M | $543M | $-206M | $-124M | |
| Liabilities + Equity | $1.47B | $1.45B | $654M | $701M | $610M | $299M | · | |
| Shares Outstanding | 528,182,693 | 396,802,394 | 234,270,384 | 191,022,864 | 170,272,462 | 22,314,685 | 21,637,609 |
현금 흐름 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $36M | $24M | $12M | $8M | $4M | $2M | |
| Stock-based Comp | $111M | $82M | $54M | $28M | $15M | $4M | $1M | |
| Deferred Tax | $-368.0K | $-2M | $-4M | $0 | · | · | · | |
| Amort. of Intangibles | $50M | $19M | $8M | $379.0K | $304.0K | $126.0K | $0 | |
| Restructuring | $10M | · | · | · | · | · | · | |
| Other Non-cash | $78M | $-12M | $-38M | $116M | $5M | · | · | |
| Operating Cash Flow | $-372M | $-359M | $-288M | $-84M | $-159M | $-45M | $-57M | |
| CapEx | $6M | $14M | $12M | $37M | $40M | $6M | $4M | |
| Investing Cash Flow | $-17M | $260M | $-10M | $193M | $-272M | $-9M | $-4M | |
| Net Debt Issued | · | · | $-766.0K | $-90.0K | $-13M | · | · | |
| Stock Issued | $529M | $300M | $128M | $144M | $463M | $0 | · | |
| Net Stock Activity | $529M | $300M | $128M | $144M | · | · | · | |
| Financing Cash Flow | $522M | $304M | $140M | $154M | $459M | $246M | $120M | |
| Net Change in Cash | $151M | $202M | $-158M | $264M | $28M | $192M | $59M | |
| Taxes Paid | $237.0K | $0 | · | · | · | · | · | |
| Free Cash Flow | $-378M | $-373M | $-300M | $-121M | $-198M | · | · | |
| Levered FCF | · | · | $-300M | · | · | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -867.9% | -814.1% | -785.3% | -616.7% | -1795.8% | · | · | |
| Net Margin | -863.4% | -788.0% | -736.0% | -601.1% | -1832.2% | · | · | |
| Pretax Margin | -863.5% | -789.9% | -745.1% | · | · | · | · | |
| EBITDA Margin | -755.8% | -752.1% | -730.6% | -587.2% | -1713.2% | · | · | |
| ROA | -44.1% | -44.1% | -48.4% | -36.5% | -41.0% | · | · | |
| ROE | -62.9% | -59.5% | -72.8% | -54.8% | -32.7% | · | · | |
| ROIC | -57.3% | -46.2% | -74.6% | · | · | · | · |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 3.8 | 4.7 | 5.7 | 11.5 | · | · | |
| Quick Ratio | 5.0 | 3.2 | 4.2 | 5.5 | 11.1 | · | · | |
| Debt / Equity | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | -3608.9 | -4467.8 | -61.9 | · | · |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | · | · | |
| Receivables Turnover | · | · | · | 2343.7 | 107.1 | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 26.9% | 32.0% | 11.9% | 291.5% | 156.9% | · | · | |
| Revenue CAGR 3Y | 23.3% | 79.5% | 124.1% | · | · | · | · | |
| Revenue CAGR 5Y | 79.9% | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75M | $59M | $45M | $40M | $10M | · | · | |
| Net Income TTM | $-645M | $-464M | $-328M | $-239M | $-186M | · | · | |
| Market Cap | $2.16B | $2.68B | $2.31B | $1.47B | $2.92B | · | · | |
| Enterprise Value | · | · | $1.92B | $923M | $2.40B | · | · | |
| P/E | -2.8 | -4.0 | -6.2 | -5.7 | -11.5 | · | · | |
| P/S | 28.9 | 45.6 | 51.8 | 37.0 | 286.6 | · | · | |
| P/B | 1.9 | 2.6 | 5.0 | 3.0 | 5.4 | · | · | |
| P / Tangible Book | 3.3 | 4.9 | 6.2 | 3.0 | 5.4 | · | · | |
| P / Cash Flow | -5.8 | -7.5 | -8.0 | -17.6 | -18.4 | · | · | |
| P / FCF | -5.7 | -7.2 | -7.7 | -12.2 | -14.7 | · | · | |
| EV / EBITDA | · | · | -5.9 | -3.9 | -13.8 | · | · | |
| EV / FCF | · | · | -6.4 | -7.7 | -12.1 | · | · | |
| EV / Revenue | · | · | 43.0 | 23.2 | 235.8 | · | · | |
| Earnings Yield | -35.2% | -25.0% | -16.0% | -17.6% | -8.7% | · | · |
손익계산서 16
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $36M | $5M | $19M | $15M | $5M | $26M | $14M | $14M | $11M | $11M | $11M | $12M | $14M | $13M | $8M | |
| Cost of Revenue | $12M | $14M | $15M | $20M | $22M | $13M | $12M | $9M | $11M | $10M | $11M | $9M | $12M | $11M | $15M | $14M | |
| R&D Expense | $88M | $96M | $121M | $129M | $130M | $98M | $75M | $74M | $68M | $69M | $70M | $55M | $47M | $44M | $41M | $38M | |
| SG&A Expense | $35M | $34M | $42M | $47M | $55M | $77M | $38M | $32M | $31M | $30M | $29M | $28M | $23M | $20M | $19M | $21M | |
| Operating Expenses | $135M | $144M | $177M | $195M | $206M | $188M | $124M | $115M | $110M | $110M | $110M | $93M | $82M | $75M | $76M | $74M | |
| Operating Income | $-129M | $-108M | $-172M | $-176M | $-191M | $-184M | $-98M | $-101M | $-96M | $-99M | $-100M | $-82M | $-70M | $-61M | $-63M | $-66M | |
| Interest Expense | · | · | · | · | · | · | · | · | $20.0K | · | $25.0K | $26.0K | $19.0K | · | $13.0K | $14.0K | |
| Other Non-op | $6M | $232.0K | $10M | $4M | $-11M | $5M | $3M | $2M | $4M | $2M | $7M | $5M | $5M | $3M | $2M | $631.0K | |
| Pretax Income | $-122M | $-108M | $-162M | $-172M | $-203M | $-179M | $-96M | $-98M | $-92M | $-97M | $-93M | $-77M | $-65M | · | · | · | |
| Income Tax | $-5M | $19.0K | $3.0K | $0 | $-158.0K | $8.0K | $167.0K | $-523.0K | $-779.0K | $-4M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-118M | $-108M | $-162M | $-172M | $-202M | $-179M | $-96M | $-98M | $-91M | $-93M | $-93M | $-77M | $-65M | $-57M | $-60M | $-66M | |
| EPS (Basic) | $-0.22 | $-0.17 | $-0.36 | $-0.41 | $-0.50 | $-0.56 | $-0.34 | $-0.40 | $-0.39 | $-0.43 | $-0.43 | $-0.38 | $-0.34 | $-0.30 | $-0.35 | $-0.38 | |
| EPS (Diluted) | $-0.22 | $-0.17 | $-0.36 | $-0.41 | $-0.50 | $-0.56 | $-0.34 | $-0.40 | $-0.39 | $-0.43 | $-0.43 | $-0.38 | $-0.34 | $-0.30 | $-0.35 | $-0.38 | |
| Shares (Basic) | 529,303,984 | -819,675,056 | 446,988,046 | 417,361,147 | 402,771,972 | -486,591,660 | 282,583,048 | 242,196,409 | 236,019,349 | -399,507,197 | 214,327,186 | 201,415,475 | 191,618,238 | -340,801,265 | 173,435,970 | 172,212,390 | |
| Shares (Diluted) | 529,303,984 | -819,675,056 | 446,988,046 | 417,361,147 | 402,771,972 | -486,591,660 | 282,583,048 | 242,196,409 | 236,019,349 | -399,507,197 | 214,327,186 | 201,415,475 | 191,618,238 | -340,801,265 | 173,435,970 | 172,212,390 | |
| EBITDA | $-109M | · | $-172M | $-176M | $-172M | · | $-98M | $-101M | $-89M | · | $-100M | $-82M | $-66M | · | $-63M | $-66M |
대차대조표 29
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $654M | $743M | $660M | $525M | $500M | $594M | $428M | $474M | $296M | · | $387M | $406M | $473M | · | $455M | $454M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $62M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $21.0K | |
| Prepaid Expense | $12M | $12M | $0 | $0 | $2M | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $24M | $29M | $29M | $37M | $32M | $38M | $43M | $44M | $41M | · | $18M | $19M | $16M | · | $13M | $17M | |
| Current Assets | $710M | $813M | $714M | $587M | $584M | $714M | $474M | $522M | $344M | · | $411M | $431M | $492M | · | $482M | $546M | |
| PP&E (Net) | $96M | $104M | $112M | $120M | $127M | $141M | $84M | $84M | $87M | · | $86M | $90M | $90M | · | $86M | $82M | |
| PP&E (Gross) | · | $193M | · | · | · | $204M | $141M | $136M | $136M | · | $127M | $127M | $124M | · | $113M | $106M | |
| Accum. Depreciation | · | $89M | · | · | · | $63M | $56M | $52M | $49M | · | $41M | $38M | $34M | · | $27M | $24M | |
| Goodwill | $160M | $162M | $162M | $164M | $158M | $149M | $52M | $52M | $52M | $52M | $53M | $61M | $801.0K | $801.0K | $801.0K | $801.0K | |
| Intangibles | $294M | $310M | $322M | $341M | $336M | $336M | $34M | $38M | $33M | · | $39M | $43M | $1M | · | $1M | $1M | |
| Other Non-current Assets | $12M | $13M | $15M | $9M | $15M | $9M | $360.0K | $308.0K | $254.0K | · | $155.0K | $110.0K | $82.0K | · | $0 | $0 | |
| Total Assets | $1.34B | $1.47B | $1.40B | $1.30B | $1.31B | $1.45B | $726M | $776M | $558M | · | $631M | $667M | $627M | · | $612M | $673M | |
| Accounts Payable | $20M | $18M | $14M | $19M | $25M | $22M | $2M | $4M | $5M | · | $4M | $2M | $4M | · | $4M | $3M | |
| Accrued Liabilities | $54M | $70M | $53M | $64M | $57M | $82M | $41M | $33M | $26M | · | $40M | $33M | $25M | · | $27M | $24M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $55.0K | · | $695.0K | $676.0K | $661.0K | · | $95.0K | $93.0K | |
| Current Liabilities | $130M | $148M | $155M | $164M | $142M | $187M | $109M | $86M | $74M | · | $94M | $114M | $92M | · | $83M | $97M | |
| Capital Leases | $43M | $47M | $50M | $53M | $56M | $67M | $54M | $50M | $44M | · | $44M | $46M | $47M | · | $46M | $48M | |
| Deferred Tax | $18M | $23M | $23M | $24M | $22M | $17M | $168.0K | $0 | $528.0K | · | $2M | $4M | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $1M | $2M | $5M | $5M | $3M | $3M | · | · | · | · | · | · | · | · | |
| Total Liabilities | $315M | $343M | $353M | $383M | $371M | $414M | $202M | $191M | $157M | · | $193M | $198M | $197M | · | $223M | $235M | |
| Total Debt | · | · | · | · | · | · | · | · | $55.0K | · | $695.0K | $676.0K | $661.0K | · | $95.0K | $93.0K | |
| Common Stock | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | |
| Paid-in Capital | $3.19B | $3.17B | $2.98B | $2.68B | $2.55B | $2.47B | $1.78B | $1.74B | $1.46B | · | $1.31B | $1.25B | $1.14B | · | $970M | $959M | |
| Retained Earnings | $-2.19B | $-2.08B | $-1.97B | $-1.81B | $-1.63B | $-1.43B | $-1.25B | $-1.16B | $-1.06B | · | $-875M | $-782M | $-705M | · | $-582M | $-522M | |
| AOCI | $27M | $37M | $34M | $44M | $14M | $-8M | · | · | · | · | · | · | · | · | $0 | $-197.0K | |
| Stockholders' Equity | $1.02B | $1.13B | $1.05B | $919M | $934M | $1.03B | $525M | $584M | $401M | $463M | $438M | $469M | $430M | $486M | $388M | $438M | |
| Liabilities + Equity | $1.34B | $1.47B | $1.40B | $1.30B | $1.31B | $1.45B | $726M | $776M | $558M | · | $631M | $667M | $627M | · | $612M | $673M | |
| Shares Outstanding | 530,628,653 | 528,182,693 | 491,800,501 | 432,830,642 | 406,410,733 | 396,802,394 | 286,124,279 | 280,968,276 | 237,508,682 | 234,270,384 | 216,313,682 | 206,737,332 | 192,230,854 | 191,022,864 | 174,072,906 | 172,815,409 |
현금 흐름 16
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20M | $19M | $21M | $24M | $19M | $13M | $7M | $9M | $7M | $8M | $8M | $6M | $4M | $3M | $3M | $3M | |
| Stock-based Comp | $22M | $24M | $25M | $26M | $36M | $31M | $18M | $17M | $16M | $16M | $17M | $12M | $9M | $8M | $9M | $6M | |
| Deferred Tax | $-5M | · | · | · | $-419.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $13M | $13M | $13M | $12M | $12M | $7M | $4M | $4M | $3M | $3M | $3M | $2M | $152.0K | $151.0K | $76.0K | $76.0K | |
| Restructuring | · | $1M | $73.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-888.0K | · | · | · | $15M | · | · | · | $-34M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $-81M | $-46M | $-117M | $-76M | $-132M | $-115M | $-59M | $-82M | $-102M | $-74M | $-73M | $-67M | $-73M | $-45M | $-55M | $-62M | |
| CapEx | $258.0K | $1M | $243.0K | $3M | $2M | $1M | $5M | $1M | $7M | $2M | $745.0K | $4M | $5M | $8M | $8M | $16M | |
| Investing Cash Flow | $-338.0K | $-1M | $-3M | $-6M | $-7M | $275M | $-5M | $-4M | $-7M | $-2M | $-347.0K | $-2M | $-5M | $-8M | $53M | $5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $-26.0K | · | · | · | $-24.0K | · | · | · | |
| Stock Issued | $0 | $133M | $254M | $100M | $41M | $11M | $17M | $262M | $11M | $78M | $50M | $0 | $0 | · | · | · | |
| Net Stock Activity | $0 | · | · | · | $41M | · | · | · | $11M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-3M | $132M | $251M | $98M | $41M | $11M | $16M | $263M | $14M | $81M | $54M | $4M | $2M | $147M | $2M | $3M | |
| Net Change in Cash | $-89M | $87M | $133M | $25M | $-94M | $167M | $-47M | $177M | $-95M | $4M | $-20M | $-66M | $-77M | $94M | $780.0K | $-54M | |
| Free Cash Flow | $-81M | · | · | · | $-134M | · | · | · | $-109M | · | · | · | $-78M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $-109M | · | · | · | · | · | · | · |
수익성 7
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1985.5% | · | -3327.6% | -916.8% | -1297.9% | · | -377.1% | -697.4% | -698.4% | · | -945.1% | -741.7% | -575.8% | · | -475.5% | -862.5% | |
| Net Margin | -1815.6% | · | -3135.3% | -894.2% | -1373.3% | · | -367.5% | -676.6% | -662.4% | · | -883.1% | -696.4% | -538.4% | · | -459.3% | -854.3% | |
| Pretax Margin | -1886.7% | · | -3135.3% | -894.2% | -1374.3% | · | -366.8% | -680.2% | -668.1% | · | · | · | · | · | · | · | |
| EBITDA Margin | -1681.6% | · | -3327.6% | -916.8% | -1166.8% | · | -377.1% | -697.4% | -644.9% | · | -945.1% | -741.7% | -545.1% | · | -475.5% | -862.5% | |
| ROA | -8.9% | · | -15.3% | -16.5% | -21.7% | · | -14.1% | -13.5% | -15.4% | · | -15.0% | -11.5% | -9.6% | · | -9.5% | -9.6% | |
| ROE | -12.0% | · | -20.6% | -22.9% | -30.3% | · | -19.9% | -18.5% | -22.0% | · | -22.5% | -16.9% | -14.1% | · | -12.2% | -12.1% | |
| ROIC | -12.1% | · | -16.4% | -19.2% | -20.5% | · | -18.8% | -17.1% | -23.8% | · | · | · | · | · | · | · |
유동성 및 지급능력 4
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | · | 4.6 | 3.6 | 4.1 | · | 4.4 | 6.1 | 4.6 | · | 4.4 | 3.8 | 5.3 | · | 5.8 | 5.6 | |
| Quick Ratio | 5.0 | · | 4.3 | 3.2 | 3.5 | · | 3.9 | 5.5 | 4.0 | · | 4.1 | 3.6 | 5.1 | · | 5.5 | 5.3 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -4817.0 | · | -3982.0 | -3142.9 | -3677.1 | · | -4813.3 | -4727.9 |
효율성 2
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 774.1 | 219.3 |
가치 평가 (TTM) 14
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $46M | · | $65M | $74M | $69M | · | $65M | $50M | $47M | · | $47M | $44M | $38M | · | $29M | $18M | |
| Net Income TTM | $-654M | · | $-632M | $-568M | $-487M | · | $-378M | $-359M | $-326M | · | $-296M | $-268M | $-247M | · | $-229M | $-212M | |
| Market Cap | $1.63B | · | $2.40B | $2.19B | $2.15B | · | $1.89B | $2.11B | $2.37B | · | $1.65B | $1.54B | $1.28B | · | $1.85B | $1.41B | |
| Enterprise Value | · | · | · | · | · | · | · | · | $2.07B | · | $1.27B | $1.14B | $810M | · | $1.40B | $891M | |
| P/E | -2.1 | · | -3.0 | -3.1 | -3.2 | · | -4.2 | -4.7 | -6.5 | · | -5.1 | -5.2 | -4.8 | · | -7.9 | -6.3 | |
| P/S | 35.7 | · | 36.8 | 29.4 | 31.1 | · | 29.1 | 42.3 | 49.9 | · | 35.3 | 35.1 | 33.5 | · | 64.5 | 77.8 | |
| P/B | 1.6 | · | 2.3 | 2.4 | 2.3 | · | 3.6 | 3.6 | 5.9 | · | 3.8 | 3.3 | 3.0 | · | 4.8 | 3.2 | |
| P / Tangible Book | 2.9 | · | 4.3 | 5.3 | 4.9 | · | 4.3 | 4.3 | 7.5 | · | 4.8 | 4.2 | 3.0 | · | 4.8 | 3.2 | |
| P / Cash Flow | -20.1 | · | · | · | -16.3 | · | · | · | -23.1 | · | · | · | -17.5 | · | · | · | |
| P / FCF | -20.0 | · | · | · | -16.1 | · | · | · | -21.7 | · | · | · | -16.3 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | -23.3 | · | -12.7 | -13.9 | -12.2 | · | -22.3 | -13.5 | |
| EV / FCF | · | · | · | · | · | · | · | · | -19.0 | · | · | · | -10.3 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 43.6 | · | 27.1 | 25.9 | 21.1 | · | 48.7 | 49.3 | |
| Earnings Yield | -48.5% | · | -33.0% | -32.6% | -30.8% | · | -23.7% | -21.3% | -15.4% | · | -19.6% | -19.4% | -21.0% | · | -12.6% | -16.0% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $75M | $59M | $45M | $40M | $10M |
| 영업이익률 % | -867.9% | -814.1% | -785.3% | -616.7% | -1795.8% |
| 순이익 | $-645M | $-464M | $-328M | $-239M | $-186M |
| 희석 EPS | $-1.44 | $-1.69 | $-1.58 | $-1.36 | $-1.49 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | — | 0.0 | 0.0 | 0.0 |
| 유동비율 | 5.5 | 3.8 | 4.7 | 5.7 | 11.5 |
| 당좌 비율 | 5.0 | 3.2 | 4.2 | 5.5 | 11.1 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-378M | $-373M | $-300M | $-121M | $-198M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.